Introduction
Lakshmi Santhanam, Johns Hopkins University School of Medicine
Lakshmi Santhanam, Johns Hopkins University School of Medicine
09:30h - 09:50h
Speaker Search Results
See below speakers found that match your search terms.
Scientific Session
Auditorium
26.5.2026
09:30 – 10:45h
Mechanistic Roles of Transglutaminase in Cardiovascular and Emerging Pathologies 1
Chairs: Lakshmi Santhanam (US) TBD
Scientific Session
Auditorium
26.5.2026
09:30 – 10:45h
Mechanistic Roles of Transglutaminase in Cardiovascular and Emerging Pathologies 1
Chairs: Lakshmi Santhanam (US) TBD
Emerging role of transglutaminases in pathologies
László Fésüs, University of Debrecen, Hungary
László Fésüs, University of Debrecen, Hungary
09:50h - 10:15h
Scientific Session
Auditorium
26.5.2026
09:30 – 10:45h
Mechanistic Roles of Transglutaminase in Cardiovascular and Emerging Pathologies 1
Chairs: Lakshmi Santhanam (US) TBD
Selected Abstract 1
TBD
TBD
10:15h - 10:30h
Keynote Lecture
Auditorium
25.5.2026
16:30 – 18:00h
Opening and Keynote Lecture
Chair: Luigi Leanza (IT)
Opening Lecture - Lifetime research with transglutaminases
Mauro Piacentini, University of Rome Tor Vergata, Italy
Mauro Piacentini, University of Rome Tor Vergata, Italy
16:30h - 17:15h
Keynote Lecture
Auditorium
25.5.2026
16:30 – 18:00h
Opening and Keynote Lecture
Chair: Luigi Leanza (IT)
Keynote Lecture - Protein monoaminylation: novel mechanisms of neural development, plasticity, and disease
Ian Maze, Icahn School of Medicine at Mount Sinai, USA - (IUBMB supported Lecture)
Ian Maze, Icahn School of Medicine at Mount Sinai, USA - (IUBMB supported Lecture)
16:30h - 17:15h
Scientific Session
Auditorium
26.5.2026
09:30 – 10:45h
Mechanistic Roles of Transglutaminase in Cardiovascular and Emerging Pathologies 1
Chairs: Lakshmi Santhanam (US) TBD
Selected Abstract 2
TBD
TBD
10:30h - 10:45h
Scientific Session
Auditorium
26.5.2026
11:30 – 13:00h
Mechanistic Roles of Transglutaminase in Cardiovascular and Emerging Pathologies 2
Chairs: Lakshmi Santhanam (US) TBD
Factor XIII-A and plasma fibronectin in liver-bone crosstalk
Mari T. Kaartinen, McGill University, Canada
Mari T. Kaartinen, McGill University, Canada
11:30h - 11:55h
Scientific Session
Auditorium
26.5.2026
11:30 – 13:00h
Mechanistic Roles of Transglutaminase in Cardiovascular and Emerging Pathologies 2
Chairs: Lakshmi Santhanam (US) TBD
Short Talk #3
TBD
TBD
11:55h - 12:10h
Scientific Session
Auditorium
26.5.2026
11:30 – 13:00h
Mechanistic Roles of Transglutaminase in Cardiovascular and Emerging Pathologies 2
Chairs: Lakshmi Santhanam (US) TBD
Short Talk #4
TBD
TBD
12:10h - 12:25h
Scientific Session
Auditorium
26.5.2026
11:30 – 13:00h
Mechanistic Roles of Transglutaminase in Cardiovascular and Emerging Pathologies 2
Chairs: Lakshmi Santhanam (US) TBD
Flash Talks #1-10
TBD
TBD
12:25h - 12:40h
Scientific Session
Auditorium
26.5.2026
14:30 – 15:35h
Transglutaminase in Cancer: Mechanisms and Clinical Implications 1
Chairs: Nicoletta Bianchi (IT) TBD
Introduction
Nicoletta Bianchi, University of Ferrara, Italy
Nicoletta Bianchi, University of Ferrara, Italy
14:30h - 14:50h
Scientific Session
Auditorium
26.5.2026
14:30 – 15:35h
Transglutaminase in Cancer: Mechanisms and Clinical Implications 1
Chairs: Nicoletta Bianchi (IT) TBD
Short Talk #5
TBD
TBD
14:50h - 15:05h
Scientific Session
Auditorium
26.5.2026
14:30 – 15:35h
Transglutaminase in Cancer: Mechanisms and Clinical Implications 1
Chairs: Nicoletta Bianchi (IT) TBD
Short Talk #6
TBD
TBD
15:05h - 15:20h
Scientific Session
Auditorium
26.5.2026
14:30 – 15:35h
Transglutaminase in Cancer: Mechanisms and Clinical Implications 1
Chairs: Nicoletta Bianchi (IT) TBD
Short Talk #7
TBD
TBD
15:20h - 15:35h
Scientific Session
Auditorium
26.5.2026
17:30 – 19:00h
Transglutaminase in Cancer: Mechanisms and Clinical Implications 2
Chairs: Nicoletta Bianchi (IT) TBD
Transglutaminase 2 (TG2) exacerbates ovarian cancer survival by directly inactivating GSK3β: Is TG2 a primordial chaperone for tumor suppressors?
Soo-Youl Kim, National Cancer Centre, Korea
Soo-Youl Kim, National Cancer Centre, Korea
17:30h - 17:55h
Scientific Session
Auditorium
26.5.2026
17:30 – 19:00h
Transglutaminase in Cancer: Mechanisms and Clinical Implications 2
Chairs: Nicoletta Bianchi (IT) TBD
Short Talk #8
TBD
TBD
17:55h - 18:10h
Scientific Session
Auditorium
26.5.2026
17:30 – 19:00h
Transglutaminase in Cancer: Mechanisms and Clinical Implications 2
Chairs: Nicoletta Bianchi (IT) TBD
Short Talk #9
TBD
TBD
18:10h - 18:25h
Scientific Session
Auditorium
26.5.2026
17:30 – 19:00h
Transglutaminase in Cancer: Mechanisms and Clinical Implications 2
Chairs: Nicoletta Bianchi (IT) TBD
Flash Talks #11-20
TBD
TBD
18:25h - 19:00h
Scientific Session
Auditorium
27.5.2026
09:30 – 10:45h
Transglutaminase Pathways in Neurodegeneration and Neurological Disorders 1
Chairs: Gail V. W. Johnson (US) TBD
Introduction
Gail V W Johnson, University of Rochester, USA
Gail V W Johnson, University of Rochester, USA
09:30h - 09:50h
Scientific Session
Auditorium
27.5.2026
09:30 – 10:45h
Transglutaminase Pathways in Neurodegeneration and Neurological Disorders 1
Chairs: Gail V. W. Johnson (US) TBD
Expanding the histone monoaminylation landscape mediated by Transglutaminases
David Vinson, Icahn School of Medicine Mount Sinai, Canada (ECR invited speaker)
David Vinson, Icahn School of Medicine Mount Sinai, Canada (ECR invited speaker)
09:50h - 10:15h
Scientific Session
Auditorium
27.5.2026
09:30 – 10:45h
Transglutaminase Pathways in Neurodegeneration and Neurological Disorders 1
Chairs: Gail V. W. Johnson (US) TBD
Short Talk #10
TBD
TBD
10:15h - 10:30h
Scientific Session
Auditorium
27.5.2026
09:30 – 10:45h
Transglutaminase Pathways in Neurodegeneration and Neurological Disorders 1
Chairs: Gail V. W. Johnson (US) TBD
Short Talk #11
TBD
TBD
10:30h - 10:45h
Scientific Session
Auditorium
27.5.2026
11:30 – 13:00h
Transglutaminase Pathways in Neurodegeneration and Neurological Disorders 2
Chairs: Gail V. W. Johnson (US) TBD
TBD
Anne Marie Van Dam, VU Univ Medical Center Amsterdam, The Netherlands
Anne Marie Van Dam, VU Univ Medical Center Amsterdam, The Netherlands
11:30h - 11:55h
Scientific Session
Auditorium
27.5.2026
11:30 – 13:00h
Transglutaminase Pathways in Neurodegeneration and Neurological Disorders 2
Chairs: Gail V. W. Johnson (US) TBD
Short Talk #12
TBD
TBD
11:55h - 12:10h
Scientific Session
Auditorium
27.5.2026
11:30 – 13:00h
Transglutaminase Pathways in Neurodegeneration and Neurological Disorders 2
Chairs: Gail V. W. Johnson (US) TBD
Short Talk #13
TBD
TBD
12:10h - 12:25h
Scientific Session
Auditorium
27.5.2026
11:30 – 13:00h
Transglutaminase Pathways in Neurodegeneration and Neurological Disorders 2
Chairs: Gail V. W. Johnson (US) TBD
Flash Talk #21-30
TBD
TBD
12:25h - 12:40h
Young Scientists Training
Auditorium
27.5.2026
14:30 – 15:30h
Young scientists training session
Chair: Karoly Jambrovics (HU)
How to prepare a scientific talk
TBD
TBD
14:30h - 14:50h
Young Scientists Training
Auditorium
27.5.2026
14:30 – 15:30h
Young scientists training session
Chair: Karoly Jambrovics (HU)
How to prepare a grant proposal
TBD
TBD
14:50h - 15:10h
Young Scientists Training
Auditorium
27.5.2026
14:30 – 15:30h
Young scientists training session
Chair: Karoly Jambrovics (HU)
Academia vs Industry: the perspective for the scientists
TBD
TBD
15:10h - 15:30h
Scientific Session
Auditorium
27.5.2026
15:30 – 16:45h
Signaling Pathways: How Transglutaminase Shapes Cell Fate 1
Chairs: Kiyotaka Hitomi (JP) TBD
Introduction
Kiyotaka Hitomi, Nagoya University, Japan
Kiyotaka Hitomi, Nagoya University, Japan
15:30h - 15:50h
Scientific Session
Auditorium
27.5.2026
15:30 – 16:45h
Signaling Pathways: How Transglutaminase Shapes Cell Fate 1
Chairs: Kiyotaka Hitomi (JP) TBD
Moonlighting transglutaminases: Revealing RNA-binding ability of family members
Robert Kiraly, University of Debrecen, Hungary
Robert Kiraly, University of Debrecen, Hungary
15:50h - 16:15h
Scientific Session
Auditorium
27.5.2026
15:30 – 16:45h
Signaling Pathways: How Transglutaminase Shapes Cell Fate 1
Chairs: Kiyotaka Hitomi (JP) TBD
Short Talk #14
TBD
TBD
16:15h - 16:30h
Scientific Session
Auditorium
27.5.2026
15:30 – 16:45h
Signaling Pathways: How Transglutaminase Shapes Cell Fate 1
Chairs: Kiyotaka Hitomi (JP) TBD
Short Talk #15
TBD
TBD
16:30h - 16:45h
Scientific Session
Auditorium
27.5.2026
17:15 – 18:45h
Signaling Pathways: How Transglutaminase Shapes Cell Fate 2
Chairs: Kiyotaka Hitomi (JP) TBD
Structural studies of transglutaminases
Julie Elisabeth Heggelund, University of Oslo, Norway - (ECR invited speaker)
Julie Elisabeth Heggelund, University of Oslo, Norway - (ECR invited speaker)
17:15h - 17:40h
Scientific Session
Auditorium
27.5.2026
17:15 – 18:45h
Signaling Pathways: How Transglutaminase Shapes Cell Fate 2
Chairs: Kiyotaka Hitomi (JP) TBD
Short Talk #16
TBD
TBD
17:40h - 17:55h
Scientific Session
Auditorium
27.5.2026
17:15 – 18:45h
Signaling Pathways: How Transglutaminase Shapes Cell Fate 2
Chairs: Kiyotaka Hitomi (JP) TBD
Short Talk #17
TBD
TBD
17:55h - 18:10h
Scientific Session
Auditorium
27.5.2026
17:15 – 18:45h
Signaling Pathways: How Transglutaminase Shapes Cell Fate 2
Chairs: Kiyotaka Hitomi (JP) TBD
Flash Talks #31-40
TBD
TBD
18:10h - 18:25h
Scientific Session
Elettra
28.5.2026
09:30 – 10:45h
Transglutaminase-Mediated Regulation of ECM Dynamics and Fibrotic Process 1
Chairs: Elisabetta V. Edwards (UK) TBD
Introduction
Elisabetta V. Edwards, Nottingham Trent University, UK and University of Bologna IT
Elisabetta V. Edwards, Nottingham Trent University, UK and University of Bologna IT
09:30h - 09:50h
Scientific Session
Elettra
28.5.2026
09:30 – 10:45h
Transglutaminase-Mediated Regulation of ECM Dynamics and Fibrotic Process 1
Chairs: Elisabetta V. Edwards (UK) TBD
TBD
Timothy Johnson, Mestag Therapeutics, UK
Timothy Johnson, Mestag Therapeutics, UK
09:50h - 10:15h
Scientific Session
Elettra
28.5.2026
09:30 – 10:45h
Transglutaminase-Mediated Regulation of ECM Dynamics and Fibrotic Process 1
Chairs: Elisabetta V. Edwards (UK) TBD
Short Talk #18
TBD
TBD
10:15h - 10:30h
Scientific Session
Elettra
28.5.2026
09:30 – 10:45h
Transglutaminase-Mediated Regulation of ECM Dynamics and Fibrotic Process 1
Chairs: Elisabetta V. Edwards (UK) TBD
Short Talk #19
TBD
TBD
10:30h - 10:45h
Scientific Session
Elettra
28.5.2026
11:30 – 12:30h
Transglutaminase-Mediated Regulation of ECM Dynamics and Fibrotic Process 2
Chairs: Elisabetta V. Edwards (UK) TBD
Preclinical Evidence from a Humanized Mouse Model
Fabio Stellari, Experimental Pharmacology & Translational Science Department – CHIESI
Fabio Stellari, Experimental Pharmacology & Translational Science Department – CHIESI
11:30h - 11:45h
Scientific Session
Elettra
28.5.2026
11:30 – 12:30h
Transglutaminase-Mediated Regulation of ECM Dynamics and Fibrotic Process 2
Chairs: Elisabetta V. Edwards (UK) TBD
Short Talk #20
TBD
TBD
12:00h - 12:15h
Scientific Session
Elettra
28.5.2026
11:30 – 12:30h
Transglutaminase-Mediated Regulation of ECM Dynamics and Fibrotic Process 2
Chairs: Elisabetta V. Edwards (UK) TBD
Short Talk #21
TBD
TBD
12:15h - 12:30h
Scientific Session
Elettra
28.5.2026
14:30 – 15:35h
Triggering the Immune system: Transglutaminase in Celiac Disease and Inflammation 1
Chairs: Ludvig Sollid (NO) TBD
Introduction
Ludvig Sollid, University of Oslo, Norway
Ludvig Sollid, University of Oslo, Norway
14:30h - 14:50h
Scientific Session
Elettra
28.5.2026
14:30 – 15:35h
Triggering the Immune system: Transglutaminase in Celiac Disease and Inflammation 1
Chairs: Ludvig Sollid (NO) TBD
Short Talk #22
TBD
TBD
14:50h - 15:05h
Scientific Session
Elettra
28.5.2026
14:30 – 15:35h
Triggering the Immune system: Transglutaminase in Celiac Disease and Inflammation 1
Chairs: Ludvig Sollid (NO) TBD
Short Talk #23
TBD
TBD
15:05h - 15:20h
Scientific Session
Elettra
28.5.2026
14:30 – 15:35h
Triggering the Immune system: Transglutaminase in Celiac Disease and Inflammation 1
Chairs: Ludvig Sollid (NO) TBD
Short Talk #24
TBD
TBD
15:20h - 15:35h
Scientific Session
Elettra
28.5.2026
16:00 – 16:55h
Triggering the Immune system: Transglutaminase in Celiac Disease and Inflammation 2
Chairs: Ludvig Sollid (NO) TBD
The TG2/LRP1 Pathway for Antigen Presentation in Celiac Disease
Chaitan Khosla, Stanford University, USA
Chaitan Khosla, Stanford University, USA
16:00h - 16:25h
Scientific Session
Elettra
28.5.2026
16:00 – 16:55h
Triggering the Immune system: Transglutaminase in Celiac Disease and Inflammation 2
Chairs: Ludvig Sollid (NO) TBD
Short Talk #25
TBD
TBD
16:25h - 16:40h
Scientific Session
Elettra
28.5.2026
16:00 – 16:55h
Triggering the Immune system: Transglutaminase in Celiac Disease and Inflammation 2
Chairs: Ludvig Sollid (NO) TBD
Short Talk #26
TBD
TBD
16:40h - 16:55h
Scientific Session
Elettra
29.5.2026
09:30 – 11:00h
Tools and Strategies for Modulating Transglutaminase Activity
Chairs: Jeffrey W. Keillor (CA) TBD
Introduction
Jeffrey W Keillor, University of Ottawa, Canada
Jeffrey W Keillor, University of Ottawa, Canada
09:30h - 09:50h
Scientific Session
Elettra
29.5.2026
09:30 – 11:00h
Tools and Strategies for Modulating Transglutaminase Activity
Chairs: Jeffrey W. Keillor (CA) TBD
TBD
Estefano Pinilla, Aarhus Universitet, Denmark - (ECR invited speaker)
Estefano Pinilla, Aarhus Universitet, Denmark - (ECR invited speaker)
09:50h - 10:15h
Scientific Session
Elettra
29.5.2026
09:30 – 11:00h
Tools and Strategies for Modulating Transglutaminase Activity
Chairs: Jeffrey W. Keillor (CA) TBD
Short Talk #27
TBD
TBD
10:15h - 10:30h
Scientific Session
Elettra
29.5.2026
09:30 – 11:00h
Tools and Strategies for Modulating Transglutaminase Activity
Chairs: Jeffrey W. Keillor (CA) TBD
Short Talk #28
TBD
TBD
10:30h - 10:45h
Scientific Session
Elettra
29.5.2026
09:30 – 11:00h
Tools and Strategies for Modulating Transglutaminase Activity
Chairs: Jeffrey W. Keillor (CA) TBD
Short Talk #29
TBD
TBD
10:45h - 11:00h
Keynote Lecture
Elettra
29.5.2026
11:30 – 12:15h
Closing Session Keynote
Chair: TBD
Towards a therapeutic solution with tissue transglutaminase degraders
Daniela Matei, Northwestern University, UK
Daniela Matei, Northwestern University, UK
11:30h - 12:15h
Scientific Session
Elettra
28.5.2026
11:30 – 12:30h
Transglutaminase-Mediated Regulation of ECM Dynamics and Fibrotic Process 2
Chairs: Elisabetta V. Edwards (UK) TBD
Pharmacological Evaluation in Diseased Human Lung Fibroblasts and Ex Vivo Lung Tissue Models
Gessica Marchini, Experimental Pharmacology & Translational Science Department – CHIESI
Gessica Marchini, Experimental Pharmacology & Translational Science Department – CHIESI
11:45h - 12:00h
FEBS has twin commitments to high-quality publications and the promotion of molecular biosciences. As a charitable academic organization,
FEBS uses income from the journals to fund its diverse activities, including support for FEBS Advanced Courses.
Federation of European Biochemical Societies
A charitable organization advancing research in the
molecular life sciences across Europe and beyond.
© Copyright Federation of European Biochemical Societies 2025. All rights reserved.